# Banner Corp: financial statements, quarterly

BANR · Nasdaq · CIK 946673 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/banr.md) · [Financials](/companies/banr/financials.md) · [Filings](/companies/banr/filings.md) · [Insiders](/companies/banr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/banr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [12.7](/filings/0000946673-24-000033.md) | [14.1 d](/filings/0000946673-26-000009.md) | [11.6](/filings/0000946673-25-000030.md) | [17.2](/filings/0000946673-25-000059.md) | [18.1](/filings/0000946673-25-000088.md) | [20.0 d](/filings/0000946673-26-000009.md) | [19.1](/filings/0000946673-26-000127.md) | [17.8](/filings/0000946673-26-000172.md) | [20.7](/filings/0000946673-25-000088.md) | [15.2 d](/filings/0000946673-26-000009.md) | [19.2](/filings/0000946673-26-000127.md) | [18.2](/filings/0000946673-26-000172.md) |
| Interest expense | $m | [37.3](/filings/0000946673-23-000038.md) | [45.3 d](/filings/0000946673-24-000008.md) | [51.7](/filings/0000946673-24-000015.md) | [56.6](/filings/0000946673-24-000025.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [10.7](/filings/0000946673-24-000033.md) | [10.7 d](/filings/0000946673-26-000009.md) | [8.8](/filings/0000946673-25-000030.md) | [9.5](/filings/0000946673-25-000059.md) | [10.6](/filings/0000946673-25-000088.md) | [11.7 d](/filings/0000946673-26-000009.md) | [10.7](/filings/0000946673-26-000127.md) | [10.5](/filings/0000946673-26-000172.md) | [12.5](/filings/0000946673-25-000088.md) | [9.8 d](/filings/0000946673-26-000009.md) | [12.8](/filings/0000946673-26-000127.md) | [11.3](/filings/0000946673-26-000172.md) |
| Net income | $m | [45.9](/filings/0000946673-24-000033.md) | [42.6](/filings/0000946673-24-000033.md) | [37.6](/filings/0000946673-25-000088.md) | [39.8](/filings/0000946673-25-000088.md) | [45.2](/filings/0000946673-25-000088.md) | [46.4](/filings/0000946673-25-000088.md) | [45.1](/filings/0000946673-26-000172.md) | [45.5](/filings/0000946673-26-000172.md) | [53.5](/filings/0000946673-26-000172.md) | [51.2](/filings/0000946673-26-000172.md) | [54.7](/filings/0000946673-26-000172.md) | [48.9](/filings/0000946673-26-000172.md) |
| Diluted EPS | $ per share | [1.33](/filings/0000946673-24-000033.md) | not reported | [1.09](/filings/0000946673-25-000030.md) | [1.15](/filings/0000946673-25-000059.md) | [1.30](/filings/0000946673-25-000088.md) | not reported | [1.30](/filings/0000946673-26-000127.md) | [1.31](/filings/0000946673-26-000172.md) | [1.54](/filings/0000946673-25-000088.md) | not reported | [1.60](/filings/0000946673-26-000127.md) | [1.43](/filings/0000946673-26-000172.md) |
| Basic EPS | $ per share | [1.33](/filings/0000946673-24-000033.md) | not reported | [1.09](/filings/0000946673-25-000030.md) | [1.15](/filings/0000946673-25-000059.md) | [1.31](/filings/0000946673-25-000088.md) | not reported | [1.31](/filings/0000946673-26-000127.md) | [1.31](/filings/0000946673-26-000172.md) | [1.55](/filings/0000946673-25-000088.md) | not reported | [1.61](/filings/0000946673-26-000127.md) | [1.44](/filings/0000946673-26-000172.md) |

- Revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0000946673-23-000038.md) | [0.3](/filings/0000946673-25-000008.md) | [0.2](/filings/0000946673-24-000015.md) | [0.2](/filings/0000946673-24-000025.md) | [0.5](/filings/0000946673-24-000033.md) | [0.5](/filings/0000946673-26-000009.md) | [0.4](/filings/0000946673-25-000030.md) | [0.5](/filings/0000946673-25-000059.md) | [0.7](/filings/0000946673-25-000088.md) | [0.4](/filings/0000946673-26-000172.md) | [0.4](/filings/0000946673-26-000127.md) | [0.4](/filings/0000946673-26-000172.md) |
| Total assets | $bn | [15.5](/filings/0000946673-23-000038.md) | [15.7](/filings/0000946673-25-000008.md) | [15.5](/filings/0000946673-24-000015.md) | [15.8](/filings/0000946673-24-000025.md) | [16.2](/filings/0000946673-24-000033.md) | [16.2](/filings/0000946673-26-000009.md) | [16.2](/filings/0000946673-25-000030.md) | [16.4](/filings/0000946673-25-000059.md) | [16.6](/filings/0000946673-25-000088.md) | [16.4](/filings/0000946673-26-000172.md) | [16.3](/filings/0000946673-26-000127.md) | [16.6](/filings/0000946673-26-000172.md) |
| Total liabilities | $bn | [14.0](/filings/0000946673-23-000038.md) | [14.0](/filings/0000946673-25-000008.md) | [13.9](/filings/0000946673-24-000015.md) | [14.1](/filings/0000946673-24-000025.md) | [14.4](/filings/0000946673-24-000033.md) | [14.4](/filings/0000946673-26-000009.md) | [14.3](/filings/0000946673-25-000030.md) | [14.6](/filings/0000946673-25-000059.md) | [14.7](/filings/0000946673-25-000088.md) | [14.4](/filings/0000946673-26-000172.md) | [14.4](/filings/0000946673-26-000127.md) | [14.6](/filings/0000946673-26-000172.md) |
| Shareholders' equity | $bn | [1.5](/filings/0000946673-24-000033.md) | [1.7](/filings/0000946673-26-000009.md) | [1.7](/filings/0000946673-25-000088.md) | [1.7](/filings/0000946673-25-000088.md) | [1.8](/filings/0000946673-25-000088.md) | [1.8](/filings/0000946673-26-000172.md) | [1.8](/filings/0000946673-26-000172.md) | [1.9](/filings/0000946673-26-000172.md) | [1.9](/filings/0000946673-26-000172.md) | [1.9](/filings/0000946673-26-000172.md) | [2.0](/filings/0000946673-26-000172.md) | [2.0](/filings/0000946673-26-000172.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [71.6 d](/filings/0000946673-24-000033.md) | [67.6 d](/filings/0000946673-26-000009.md) | [51.5](/filings/0000946673-25-000030.md) | [78.7 d](/filings/0000946673-25-000059.md) | [63.8 d](/filings/0000946673-25-000088.md) | [99.3 d](/filings/0000946673-26-000009.md) | [57.2](/filings/0000946673-26-000127.md) | [54.9 d](/filings/0000946673-26-000172.md) | [120 d](/filings/0000946673-25-000088.md) | [24.9 d](/filings/0000946673-26-000009.md) | [110](/filings/0000946673-26-000127.md) | [39.0 d](/filings/0000946673-26-000172.md) |
| Capital expenditure | $m | [6.1 d](/filings/0000946673-24-000033.md) | [3.0 d](/filings/0000946673-26-000009.md) | [2.2](/filings/0000946673-25-000030.md) | [4.4 d](/filings/0000946673-25-000059.md) | [3.3 d](/filings/0000946673-25-000088.md) | [3.8 d](/filings/0000946673-26-000009.md) | [1.7](/filings/0000946673-26-000127.md) | [2.7 d](/filings/0000946673-26-000172.md) | [1.8 d](/filings/0000946673-25-000088.md) | [3.4 d](/filings/0000946673-26-000009.md) | [0.4](/filings/0000946673-26-000127.md) | [3.5 d](/filings/0000946673-26-000172.md) |
| Dividends paid | $m | [16.5 d](/filings/0000946673-24-000033.md) | [16.5 d](/filings/0000946673-26-000009.md) | [16.7](/filings/0000946673-25-000030.md) | [16.9 d](/filings/0000946673-25-000059.md) | [16.5 d](/filings/0000946673-25-000088.md) | [16.6 d](/filings/0000946673-26-000009.md) | [16.8](/filings/0000946673-26-000127.md) | [17.1 d](/filings/0000946673-26-000172.md) | [16.6 d](/filings/0000946673-25-000088.md) | [17.1 d](/filings/0000946673-26-000009.md) | [17.3](/filings/0000946673-26-000127.md) | [18.3 d](/filings/0000946673-26-000172.md) |
| Share repurchases | $m | [0.0 d](/filings/0000946673-23-000038.md) | [0.0 d](/filings/0000946673-26-000009.md) | not reported | not reported | not reported | [0.0 d](/filings/0000946673-26-000009.md) | [0.0](/filings/0000946673-26-000127.md) | [0.0 d](/filings/0000946673-26-000172.md) | [15.8 d](/filings/0000946673-25-000088.md) | [15.8 d](/filings/0000946673-26-000009.md) | [16.1](/filings/0000946673-26-000127.md) | [0.0 d](/filings/0000946673-26-000172.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [34.4](/filings/0000946673-23-000038.md) | [34.5](/filings/0000946673-24-000015.md) | [34.4](/filings/0000946673-24-000025.md) | [34.4](/filings/0000946673-24-000033.md) | [34.5](/filings/0000946673-25-000030.md) | [34.5](/filings/0000946673-25-000059.md) | [34.7](/filings/0000946673-25-000088.md) | [34.8](/filings/0000946673-26-000127.md) | [34.7](/filings/0000946673-26-000172.md) | [34.7](/filings/0000946673-25-000088.md) | [34.3](/filings/0000946673-26-000127.md) | [34.1](/filings/0000946673-26-000172.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,984,909 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000946673-26-000172.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.